Abenis, Hemelin .

HRN: 01-11-13  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/06/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/06/2024
09/12/2024
IV
600 MG
Q6
Infected Wound
Waiting Final Action 
09/07/2024
MUPIROCIN 2%, 15G (TUBE)
09/07/2024
09/13/2024
TOPICAL
2%, Topical
TID
Infected Wound, Left Breast
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: